vs
EVOLUTION PETROLEUM CORP（EPM）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
EVOLUTION PETROLEUM CORP的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$20.7M vs $19.6M），EVOLUTION PETROLEUM CORP净利率更高（5.2% vs -177.4%，领先182.6%），EVOLUTION PETROLEUM CORP同比增速更快（2.0% vs -11.5%），过去两年EVOLUTION PETROLEUM CORP的营收复合增速更高（-5.2% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
EPM vs LAB — 直观对比
营收规模更大
EPM
是对方的1.1倍
$19.6M
营收增速更快
EPM
高出13.5%
-11.5%
净利率更高
EPM
高出182.6%
-177.4%
两年增速更快
EPM
近两年复合增速
-12.2%
损益表 — Q2 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.7M | $19.6M |
| 净利润 | $1.1M | $-34.7M |
| 毛利率 | 44.3% | 48.5% |
| 营业利润率 | 3.2% | -168.5% |
| 净利率 | 5.2% | -177.4% |
| 营收同比 | 2.0% | -11.5% |
| 净利润同比 | 158.4% | -28.8% |
| 每股收益（稀释后） | $0.03 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EPMLAB
| Q4 25 | $20.7M | — | ||
| Q3 25 | $21.3M | $19.6M | ||
| Q2 25 | $21.1M | $21.8M | ||
| Q1 25 | $22.6M | $40.8M | ||
| Q4 24 | $20.3M | — | ||
| Q3 24 | $21.9M | $22.1M | ||
| Q2 24 | $21.2M | $22.5M | ||
| Q1 24 | $23.0M | $45.5M |
净利润EPMLAB
| Q4 25 | $1.1M | — | ||
| Q3 25 | $824.0K | $-34.7M | ||
| Q2 25 | $3.4M | $-33.5M | ||
| Q1 25 | $-2.2M | $-26.0M | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $2.1M | $-26.9M | ||
| Q2 24 | $1.2M | $-45.7M | ||
| Q1 24 | $289.0K | $-32.2M |
毛利率EPMLAB
| Q4 25 | 44.3% | — | ||
| Q3 25 | 38.5% | 48.5% | ||
| Q2 25 | 46.1% | 48.8% | ||
| Q1 25 | 40.7% | 48.4% | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 46.2% | 54.9% | ||
| Q2 24 | 46.3% | 46.1% | ||
| Q1 24 | 45.2% | 53.1% |
营业利润率EPMLAB
| Q4 25 | 3.2% | — | ||
| Q3 25 | -0.4% | -168.5% | ||
| Q2 25 | 6.3% | -118.1% | ||
| Q1 25 | 7.0% | -80.8% | ||
| Q4 24 | -3.0% | — | ||
| Q3 24 | 8.5% | -120.9% | ||
| Q2 24 | 11.3% | -134.5% | ||
| Q1 24 | 9.1% | -132.2% |
净利率EPMLAB
| Q4 25 | 5.2% | — | ||
| Q3 25 | 3.9% | -177.4% | ||
| Q2 25 | 16.2% | -153.7% | ||
| Q1 25 | -9.7% | -63.8% | ||
| Q4 24 | -9.0% | — | ||
| Q3 24 | 9.4% | -122.0% | ||
| Q2 24 | 5.8% | -203.3% | ||
| Q1 24 | 1.3% | -70.6% |
每股收益（稀释后）EPMLAB
| Q4 25 | $0.03 | — | ||
| Q3 25 | $0.02 | $-0.09 | ||
| Q2 25 | $0.10 | $-0.09 | ||
| Q1 25 | $-0.07 | $-0.07 | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $0.06 | $-0.07 | ||
| Q2 24 | $0.04 | $-0.12 | ||
| Q1 24 | $0.01 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.8M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $67.5M | $399.7M |
| 总资产 | $169.3M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EPMLAB
| Q4 25 | $3.8M | — | ||
| Q3 25 | $714.0K | $129.4M | ||
| Q2 25 | $2.5M | $158.6M | ||
| Q1 25 | $5.6M | $150.9M | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $6.9M | $210.6M | ||
| Q2 24 | $6.4M | $269.8M | ||
| Q1 24 | $3.1M | $287.1M |
总债务EPMLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益EPMLAB
| Q4 25 | $67.5M | — | ||
| Q3 25 | $69.1M | $399.7M | ||
| Q2 25 | $71.8M | $424.5M | ||
| Q1 25 | $71.7M | $454.6M | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $79.6M | $489.3M | ||
| Q2 24 | $81.1M | $510.3M | ||
| Q1 24 | $83.5M | $577.3M |
总资产EPMLAB
| Q4 25 | $169.3M | — | ||
| Q3 25 | $169.1M | $539.6M | ||
| Q2 25 | $160.3M | $557.0M | ||
| Q1 25 | $156.4M | $579.6M | ||
| Q4 24 | $160.2M | — | ||
| Q3 24 | $157.9M | $681.5M | ||
| Q2 24 | $162.9M | $708.7M | ||
| Q1 24 | $166.5M | $777.7M |
负债/权益比EPMLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | 5.09× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流EPMLAB
| Q4 25 | $5.4M | — | ||
| Q3 25 | $7.8M | $-22.2M | ||
| Q2 25 | $10.5M | $-20.7M | ||
| Q1 25 | $7.3M | $-30.3M | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $7.6M | $-27.9M | ||
| Q2 24 | $8.0M | $-39.0M | ||
| Q1 24 | $3.4M | $-62.5M |
自由现金流EPMLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率EPMLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度EPMLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率EPMLAB
| Q4 25 | 5.09× | — | ||
| Q3 25 | 9.47× | — | ||
| Q2 25 | 3.06× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.69× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 11.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EPM
| Crude Oil | $10.7M | 52% |
| Natural Gas Reserves | $7.4M | 36% |
| Natural Gas Liquids Reserves | $2.5M | 12% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
